Trials / Completed
CompletedNCT00421018
Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)
Optimization of the Anti-Inflammatory Treatment of Asthma Patients Through Exhaled NO Measurements for Increased Asthma-Related Quality of Life in Primary Health Care (NOAK)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 187 (actual)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether use of exhaled NO (nitric oxide) to regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in patients with allergic asthma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Single corticosteroid inhalers and Singulair | Treatment steps according to preset algorithm |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2007-01-11
- Last updated
- 2012-08-15
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00421018. Inclusion in this directory is not an endorsement.